I agree that it is true that Allergan (NYSE:AGN) produces Tazarac for psoriasis. The revenue from that product is nothing next to Botox. In this Invest Stock Market hangout Dr. Scott Brown dissects the viability of Allergan (NYSE: AGN) as an investment.
http://millionairesguidetothestockmarket.wordpress.com/2014/06/15/invest-stock-market-allergan-inc-nyse-agn-champions-dermatological-disorder-treatments/
